238 related articles for article (PubMed ID: 28913617)
1. Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.
Geffin R; Martinez R; de Las Pozas A; Issac B; McCarthy M
J Neurovirol; 2017 Dec; 23(6):808-824. PubMed ID: 28913617
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E4 Suppresses Neuronal-Specific Gene Expression in Maturing Neuronal Progenitor Cells Exposed to HIV.
Geffin R; Martinez R; de Las Pozas A; Issac B; McCarthy M
J Neuroimmune Pharmacol; 2017 Sep; 12(3):462-483. PubMed ID: 28321820
[TBL] [Abstract][Full Text] [Related]
4. Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury.
Cipriani R; Chara JC; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2017 Jul; 14(1):147. PubMed ID: 28738875
[TBL] [Abstract][Full Text] [Related]
5. The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
Anastasiadou S; Knöll B
Exp Neurol; 2016 May; 279():243-260. PubMed ID: 26980486
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod induces neuroprotective factors in human astrocytes.
Hoffmann FS; Hofereiter J; Rübsamen H; Melms J; Schwarz S; Faber H; Weber P; Pütz B; Loleit V; Weber F; Hohlfeld R; Meinl E; Krumbholz M
J Neuroinflammation; 2015 Sep; 12():184. PubMed ID: 26419927
[TBL] [Abstract][Full Text] [Related]
7. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
Zhao P; Yang X; Yang L; Li M; Wood K; Liu Q; Zhu X
FASEB J; 2017 Jan; 31(1):172-179. PubMed ID: 27671228
[TBL] [Abstract][Full Text] [Related]
9. Neuronal Metabolism and Neuroprotection: Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage.
Gil A; Martín-Montañez E; Valverde N; Lara E; Boraldi F; Claros S; Romero-Zerbo SY; Fernández O; Pavia J; Garcia-Fernandez M
Cells; 2020 Dec; 10(1):. PubMed ID: 33383658
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathways.
Baer A; Colon-Moran W; Bhattarai N
Sci Rep; 2018 Jul; 8(1):10910. PubMed ID: 30026610
[TBL] [Abstract][Full Text] [Related]
12. Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.
Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
Mol Ther; 2017 Feb; 25(2):401-415. PubMed ID: 28153091
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod protects cultured cortical neurons against excitotoxic death.
Di Menna L; Molinaro G; Di Nuzzo L; Riozzi B; Zappulla C; Pozzilli C; Turrini R; Caraci F; Copani A; Battaglia G; Nicoletti F; Bruno V
Pharmacol Res; 2013 Jan; 67(1):1-9. PubMed ID: 23073075
[TBL] [Abstract][Full Text] [Related]
14. The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor.
Kaneider NC; Lindner J; Feistritzer C; Sturn DH; Mosheimer BA; Djanani AM; Wiedermann CJ
FASEB J; 2004 Aug; 18(11):1309-11. PubMed ID: 15208267
[TBL] [Abstract][Full Text] [Related]
15. FTY720 attenuates excitotoxicity and neuroinflammation.
Cipriani R; Chara JC; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2015 May; 12():86. PubMed ID: 25953296
[TBL] [Abstract][Full Text] [Related]
16. FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing.
Das A; Arifuzzaman S; Kim SH; Lee YS; Jung KH; Chai YG
Neuropharmacology; 2017 Jun; 119():1-14. PubMed ID: 28373076
[TBL] [Abstract][Full Text] [Related]
17. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models.
Vidal-Martinez G; Segura-Ulate I; Yang B; Diaz-Pacheco V; Barragan JA; De-Leon Esquivel J; Chaparro SA; Vargas-Medrano J; Perez RG
Exp Neurol; 2020 Mar; 325():113120. PubMed ID: 31751571
[TBL] [Abstract][Full Text] [Related]
18. Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).
Yazdi A; Baharvand H; Javan M
Neuroscience; 2015 Dec; 311():34-44. PubMed ID: 26475743
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T Cell Depletion by FTY720 Exacerbates Hypoxic-Ischemic Brain Injury in Neonatal Mice.
Herz J; Köster C; Crasmöller M; Abberger H; Hansen W; Felderhoff-Müser U; Bendix I
Front Immunol; 2018; 9():1696. PubMed ID: 30127782
[TBL] [Abstract][Full Text] [Related]
20. Fingolimod inhibits multiple stages of the HIV-1 life cycle.
Resop RS; Fromentin R; Newman D; Rigsby H; Dubrovsky L; Bukrinsky M; Chomont N; Bosque A
PLoS Pathog; 2020 Aug; 16(8):e1008679. PubMed ID: 32790802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
